Tradestie Institutional Equity Comparison Engine
REGN vs GNPX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
REGN Overall Edge
REGN Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Regeneron Pharmaceuticals Inc (REGN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, REGN trades at 14.8x Forward P/E with 30.4% operating margin (+36.3% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, REGN sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
REGN
REGN 14.8x vs GNPX N/M Fwd P/E
Growth & Margin Winner
REGN
Op Margin 30.4% vs 0.0% ยท YoY +36.3% vs +0.0%
Momentum & Technical Winner
REGN
1Y +31.0% vs -56.6% ยท 52W Pos 82% vs 11%
Options & Structure Winner
REGN
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
REGN
NASDAQ
Regeneron Pharmaceuticals Inc
Pharmaceutical Preparations
$920.69
-0.29% 1D
Market Cap
$95.5B
1M Return
+12.4%
1Y Return
+31.01%
Forward P/E
14.8x
Unified AI Score
46.0 / 100
HOLD
Tech 29.0
Fund 49.0
Flow 69.0
Mom 56.0
GNPX
NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap
$2.2M
1M Return
-26.77%
1Y Return
-56.59%
Forward P/E
N/M
Unified AI Score
42.2 / 100
HOLD
Tech 25.0
Fund 47.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
REGN +31.01%
GNPX -56.59%
Spread: +87.6 pp (REGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
REGN TTM Op. Margin: 30.4%
GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on REGN vs GNPX. Trailing 12-month operating profitability (REGN 30.4% vs GNPX 0.0%) and valuation multiples (REGN 14.8x vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | REGN | GNPX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $95.5B | $2.2M | Larger Scale | REGN |
| Trailing P/E Ratio Valuation | 20.4x | N/M | Lower Multiple | REGN |
| Forward P/E Ratio Valuation | 14.8x | N/M | Lower Multiple | REGN |
| Revenue Growth (YoY) Growth | +36.3% | +0.0% | Higher Growth | REGN |
| Operating Margin (TTM) Profitability | 30.4% | 0.0% | Higher Margin | REGN |
| Net Profit Margin Profitability | 28.5% | 0.0% | Higher Margin | REGN |
| Return on Equity (ROE) Capital Efficiency | 14.9% | -233.7% | Higher ROE | REGN |
| 52-Week Range Position Momentum | 82% ($592โ$992) | 11% ($0โ$10) | Stronger Trend | REGN |
| Beta / 30D Volatility Risk Regime | 0.30ฮฒ ยท 55% Vol | -4.68ฮฒ ยท 96% Vol | Lower Realized Risk | REGN |
| Unified Institutional Score Composite Signal | 46.0 / 100 (HOLD) | 42.2 / 100 (HOLD) | Higher Composite | REGN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full REGN vs GNPX Buy Guide
REGN
CONSOLIDATION
56d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
GNPX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither REGN nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.